Both histological and functional studies involving multiple cohorts have demonstrated that MCT1 (SLC16A1) and MCT4 (SLC16A3) are overexpressed in GBM and are associated with malignant phenotypes. The gene discussed is SLC16A1; the disease is glioblastoma.